 If the disease seems like it has gotten worse, you may decide to continue to receive nivolumab, if you are still eligible. It is possible the study drug may be working even though the tumors got larger. However, there are risks of continuing to receive the study drug because the disease may actually be getting worse. This is described in the side effects section below. 